Selective serotonin reuptake inhibitor (SSRI) antidepressant treatment discontinuation syndrome: A review of the clinical evidence and the possible mechanisms involved
Besides demonstrated efficacy, selective serotonin reuptake inhibitors (SSRIs) hold other advantages over earlier antidepressants such as greater tolerability and a wider range of clinical applications. However, there is a growing body of clinical evidence which suggests that SSRIs could, in some ca...
Saved in:
Main Author: | Thibault eRenoir (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2013-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The lived experience of withdrawal from Selective Serotonin Reuptake Inhibitor (SSRI) antidepressants: A qualitative interview study
by: Raqeeb Mahmood, et al.
Published: (2024) -
Suicide attempt with selective serotonin reuptake inhibitor antidepressants
by: Sandra Cuenca Carcelén, et al.
Published: (2021) -
Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors
by: Chad Compagner, et al.
Published: (2021) -
Selective Serotonin Reuptake Inhibitor Pharmaco-Omics: Mechanisms and Prediction
by: Thanh Thanh L. Nguyen, et al.
Published: (2021) -
Secondary and side effects of particular Selective Serotonin Reuptake Inhibitors (SSRIs) antidepressants - literature review
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2020)